This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: NSAIDs, Gout and Rheumatoid Ahritis, Subject name: Pharmacology
[{'content': 'Which of the following is a new oral drug approved for Rheumatoid ahritis? \nSelect and explain. \nA. UPADACITINIB, B. FEDRATINIB, C. ENTRECTINIB, D. TALAZOPARIB', 'role': 'user'}, {'content': 'Answer: A \nExplanation: UPADACITINIB : - It is an oral JAK 1 inhibitors like tofacitinib - Used for Rheumatoid ahritis to slow down the disease progression. FEDRATINIB : - It is a oral JAK 2 inhibitor . - Used for MYELOFIBROSIS ENTRECTINIB : - It is oral Tyrosine kinase inhibitor. - Used for ROS - 1 positive NON SMALL CELL LUNG CANCER and NK positive solid tumors. TALAZOPARIB : - PARP inhibitor like olaparib - Used for breast cancer.', 'role': 'assistant'}]